Kathleen Alanna Page, MD

Professor of Medicine and Pediatrics

Co-Chief, Division of Endocrinology and Diabetes

Websites

Is this your profile? Click to edit

Overview

Dr. Kathleen “Katie” Page is a physician specializing in diabetes and childhood obesity at the Keck School of Medicine of the University of Southern California (USC). She is Co-Chief of the Division of Endocrinology & Diabetes, Director of the Diabetes and Obesity Research Institute, Co-Director of Research Development at the Southern California Clinical and Translational Science Institute, Co-Director of the Investigator Development Core at the Southern California Center for Latino Health, Associate Professor of Medicine (with Tenure), and a practicing Endocrinologist in the Department of Medicine at USC.

Dr. Page has an active research program that seeks to understand the causes of obesity and diabetes so that more effective strategies can be developed for reducing the number of people affected by these health conditions. Her research has been recognized by awards from the Endocrine Society, the American Heart Association, the American Diabetes Association, and the American Federation for Medical Research. She has received grant funding from the National Institutes of Health (NIH), the American Diabetes Association, the American Heart Association and the Doris Duke Charitable Foundation.

Awards

Keck School of Medicine of USC: Dean’s Scholar Award, 2002
Genentech: Endocrine Fellows Travel Award Recipient, 2008
Endocrine Society & Amgen: Early Investigator Award, 2012
Endocrine Society: Outstanding Early Investigator Award, 2012
Western American Federation of Medical Research: Outstanding Young Investigator Award, 2012
American Heart Association: Mark Bieber Outstanding Research Award, 2014
American Diabetes Association: Pathway to Stop Diabetes Accelerator Award, 2013
– 2018
Western Society for Clinical Investigation: Outstanding Investigator Award, 2019

Education and Training

University of Southern California, Los Angeles — B.S. — 1994 — Exercise Science
University of Oklahoma, OKC, OK — M.S. — 1998 — Physiology
Keck School of Medicine of USC , Los Angeles — M.D. — 2002 — Medicine
Yale School of Medicine, New Haven, CT — 2005 — Primary Care/Internal Medicine Residency
Yale School of Medicine, New Haven, CT — 2008 — Endocrinology and Diabetes Fellowship
Yale School of Medicine, New Haven, CT — 2009 — Neuroimaging in Science Postdoctoral Fellowship

Research Funding

The Role of Gut-Brain Pathways on Childhood Obesity and Type 2 Diabetes Development
NIH · R01DK145940 · Mar 1, 2026 – Jan 31, 2031 · Role: Principal Investigator
Longitudinal Evaluation of Neurocognitive Complications in Pediatric Type 1 Diabetes Across Multi-Ethnic Groups?Exploring Risk and Protective Factors
NIH · U01DK140786 · Aug 15, 2024 – Jun 30, 2029 · Role: Principal Investigator
Effects of prenatal exposures to maternal obesity and gestational diabetes on metabolic decline from childhood to adolescence and underlying neurobiological pathways
NIH · R01DK134079 · Aug 28, 2023 – Apr 30, 2028 · Role: Principal Investigator
Acute effects of sweet flavoring and nicotine in e-cigarettes on brain activity during food decisions
NIH · R21DA055878 · Apr 1, 2022 – Mar 31, 2025 · Role: Co-Principal Investigator
Neuroendocrine Systems involved in Early-life Programming for Obesity and Diabetes
NIH · R01DK116858 · Feb 13, 2019 – Dec 31, 2024 · Role: Principal Investigator
Neuroeconomics of sugars: Glucose vs. fructose effects on reward signaling
NIH · R21DA042272 · Aug 1, 2017 – Jul 31, 2020 · Role: Co-Principal Investigator
Neural Mechanisms for Appetitive Responses to High Reward Foods
NIH · R01DK102794 · Dec 15, 2015 – Nov 30, 2021 · Role: Principal Investigator
Neural mechanisms for obestity risk in children exposed to diabetes in utero
NIH · R03DK103083 · Jul 1, 2014 – Jun 30, 2016 · Role: Principal Investigator
Maternal gestational diabetes in Hispanic youth: obesity and insulin resistance
NIH · K23DK092702 · Aug 2, 2011 – Apr 30, 2016 · Role: Principal Investigator

Media

Publications

Ketone Bodies Derived From Medium-Chain Triglycerides Support Brain Metabolism and Function Under Hypoglycemia in Type 1 Diabetes Mellitus. Diabetes. 2026 Sep 01; 75(9):1644-1656.. View in PubMed
The ecological validity of the Intuitive Eating Scale-2 among adults with binge-eating disorder. Eat Behav. 2026 Aug; 62:102109.. View in PubMed
Understanding the importance of social and environmental stressors in predicting maternal sleep quality during late pregnancy. Environ Res. 2026 Sep 01; 305(Pt 2):125013.. View in PubMed
Intrauterine gestational diabetes mellitus, child anxiety, and internalizing symptoms: moderation by physical activity. J Endocr Soc. 2026 May; 10(5):bvag095.. View in PubMed
Dietary macronutrient substitutions and cardiometabolic outcomes in children with and without gestational diabetes exposure: a cross-sectional analysis. Am J Clin Nutr. 2026 Jun; 123(6):101313.. View in PubMed
What Is Gestational Diabetes-Really? Diabetes. 2025 Jul 01; 74(7):1037-1046. Buchanan TA , Xiang AH, Page KA , Watanabe RM . . View in PubMed
The Reallocation of Sedentary Time Is Associated with Longitudinal Improvements in Cardiometabolic Outcomes during Childhood. J Pediatr. 2025 10; 285:114680.. View in PubMed
Non-caloric sweetener effects on brain appetite regulation in individuals across varying body weights. Nat Metab. 2025 Mar; 7(3):574-585.. View in PubMed
Influence of insulin sensitivity on food cue evoked functional brain connectivity in children. Neuroimage. 2025 04 15; 310:121154.. View in PubMed
Design of a randomized controlled trial to test the efficacy of interrupting sitting on type 2 diabetes risk factors in children with overweight/obesity: The sedentary behavior study 3 protocol. Contemp Clin Trials. 2025 05; 152:107862.. View in PubMed